Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems
- 1 January 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 134 (1) , 113-116
- https://doi.org/10.1016/0014-2999(87)90139-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Buspirone analogs. 2. Structure-activity relationships of aromatic imide derivativesJournal of Medicinal Chemistry, 1986
- Metabolism and disposition of buspironeThe American Journal of Medicine, 1986
- 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and RatPharmacology, 1986
- Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatmentEuropean Journal of Pharmacology, 1985
- Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activityEuropean Journal of Pharmacology, 1982
- Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of ?-adrenolytic drugsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Enhancement and Inhibition of Drug MetabolismAnnual Review of Pharmacology, 1971